January 5, 2015
The Ministry of Health, Labor and Welfare (MHLW) approved 31 products (14 active pharmaceutical ingredients) including Takeda Pharmaceutical’s Takecab (vonoprazan fumarate), a treatment for acid-related diseases, on December 26. Also among the 31 products was Eisai’s proton pump inhibitor (PPI)...read more